Evidence map›Paper›PMID 37945671›Full record

Trial reportScientific reports2023

The metabolic effects of intermittent versus continuous feeding in critically ill patients.

D Wilkinson, I J Gallagher, A McNelly, D E Bear, N Hart, H E Montgomery, A Le Guennec, M R Conte, T Francis, S D R Harridge and 2 more

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02358512 (A Phase 2 Pilot Physiological Randomised Clinical Trial to Investigate the Effect of Intermittent Versus Continuous Enteral Nutrition on Muscle Wasting in Critical Illness), which is not on this map. Cited by 14 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 3 pooled it
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02358512 phase2completednot on this map

A Phase 2 Pilot Physiological Randomised Clinical Trial to Investigate the Effect of Intermittent Versus Continuous Enteral Nutrition on Muscle Wasting in Critical Illness

TypeinterventionalSponsorGuy's and St Thomas' NHS Foundation TrustRan2015 to 2018Enrolled127ConditionsIntensive Care (ICU) MyopathyArmsEnteral feeding
3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 3 syntheses or guidelines pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Review
  7. Review
  8. Unveiling Organ Failure in the Critically Ill: Insights through the Metabolite Lens.American journal of respiratory cell and molecular biology · 2025
    Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 9 institutions in 2 countries.

D WilkinsonMRC-Versus Arthritis Centre for Musculoskeletal Ageing Research, Metabolic and Molecular Physiology, University of Nottingham, Queen's Medical Cetnre, Nottingham, UK.
I J GallagherUniversity of Sterling, Stirling, UK.
A McNellyWilliam Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
D E BearDepartment of Nutrition and Dietetics St Thomas' NHS Foundation Trust, London, UK.
N HartLane Fox Respiratory Service, Guy's & St Thomas' Foundation Trust, London, UK.
H E MontgomeryDepartment of Medicine and Centre for Human Health and Performance, University College London (UCL), London, UK.
A Le GuennecCentre for Biomolecular Spectroscopy, Guy's Campus, King's College London, London, UK.
M R ConteCentre for Biomolecular Spectroscopy, Guy's Campus, King's College London, London, UK.
T FrancisCentre for Human and Applied Physiological Science, King's College London, London, UK.
S D R HarridgeCentre for Human and Applied Physiological Science, King's College London, London, UK.
P J AthertonMRC-Versus Arthritis Centre for Musculoskeletal Ageing Research, Metabolic and Molecular Physiology, University of Nottingham, Queen's Medical Cetnre, Nottingham, UK.
Z A PuthuchearyWilliam Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK. z.puthucheary@qmul.ac.uk.
King's College London · GBGuy's and St Thomas' NHS Foundation Trust · GBKing's College - North Carolina · USQueen Mary University of London · GBRoyal Derby Hospital · GBUniversity College London · GBUniversity of Stirling · GBVersus Arthritis · GBWilliam Harvey Research Institute · GB

Funding

Department of Health RCF236/AMCN/2015Department of Health REV/CM/AM/101320Wellcome Trust
6 · The paper itself

Abstract

Intermittent (or bolus) feeding regimens in critically ill patients have been of increasing interest to clinicians and scientists. Changes in amino acid, fat and carbohydrate metabolites over time might yet deliver other benefits (e.g. modulation of the circadian rhythm and sleep, and impacts on ghrelin secretion, insulin resistance and autophagy). We set out to characterise these changes in metabolite concentration. The Intermittent versus Continuous Feeding in Critically Ill paitents study (NCT02358512) was an eight-centre single-blinded randomised controlled trial. Patients were randomised to received a continuous (control arm) or intermittent (6x/day, intervention arm) enteral feeding regimen. Blood samples were taken on trial days 1, 7 and 10 immediately before and 30 min after intermittent feeds, and at equivalent timepoints in the control arm. A pre-planned targeted metabolomic analysis was performend using Nuclear Resonance Spectroscopy. Five hundred and ninety four samples were analysed from 75 patients. A total of 24 amino acid-, 19 lipid based-, and 44 small molecule metabolite features. Across the main two axes of variation (40-60% and 6-8% of variance), no broad patterns distinguished between intermittent or continuous feeding arms, across intra-day sampling times or over the 10 days from initial ICU admission. Logfold decreases in abundance were seen in metabolites related to amino acids (Glutamine - 0.682; Alanine - 0.594), ketone body metabolism (Acetone - 0.64; 3-Hydroxybutyric Acid - 0.632; Acetonacetic Acid - 0.586), fatty acid (carnitine - 0.509) and carbohydrate metabolism ( Maltose - 0.510; Citric Acid - 0.485). 2-3 Butanediol, a by-product of sugar-fermenting microbial metabolism also decreased (- 0.489). No correlation was seen with change in quadriceps muscle mass for any of the 20 metabolites varying with time (all p > 0.05). Increasing severity of organ failure was related to increasing ketone body metabolism (3 Hydroxybutyric Acid-1 and - 3; p = 0.056 and p = 0.014), carnitine deficiency (p = 0.002) and alanine abundancy (p - 0.005). A 6-times a day intermittent feeding regimen did not alter metabolite patterns across time compared to continuous feeding in critically ill patients, either within a 24 h period or across 10 days of intervention. Future research on intermittent feeding regimens should focus on clinical process benefits, or extended gut rest and fasting.

Indexed as

Amino AcidsCritical IllnessAlanineCarnitineHumansKetonesAlanineAmino AcidsCarnitineKetones

Identifiers

PMID37945671
PMCPMC10636009
OpenAlexW4388540846

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.